Evidence-based medicine (EBM) requires thorough utilization of the best data available at the time of the act of prescription: a transversal reading of the major clinical trials, given overwhelming approval by physicians who understand and use it in their daily decision-making, is imperative.

For more than 20 years, Professor Robert Haïat (former President of the Société Française de Cardiologie) and Dr. Gérard Leroy (Head of the cardiology unit at Saint-Germain-en-Laye hospital) have analyzed the major clinical trials in cardiovascular therapy. Authors of numerous books, sponsored by the Clinical and Therapeutic Pharmacology Task Force of the French Cardiology Society, they have received several awards, including the Jean di Mattéo Prize from the French National Academy of Medicine.

Their publications — over 300,000 copies read by specialists and general practitioners — are now available in their complete form on the cardio-log website. A state-of-the-art documentary research engine enables real-time consultation of the clinical evidence analyzed in this exceptionally rich editorial collection.

Beyond the group approach which is inherent to the very principle of clinical trials, everyday medical practice focuses on a specific patient: in order to avoid consulting clinical evidence that is not relevant to this context, cardio-log allows practitioners to filter the results of their search according to their patients’ significant characteristics and medical analyses. The trials based on a population whose characteristics do not match is thus removed in real time.